A vaccine against cholera has, for the first time, received FDA approval, the agency said Friday.
To be sold as Vaxchora, the product contains live but attenuated Vibrio cholerae bacteria. It is taken as a single oral liquid dose.
The FDA said that, since cholera is rare in the U.S., the vaccine is indicated primarily for people traveling to areas where the infection is endemic. It should be taken at least 10 days before travel to such areas.
Read Full Article »